Maps
Magazine

HEALTH

DRAP Flags Dangerous Syringes Over Sterility Concerns
DRAP alerts public on substandard syringes! Zindagi Auto Disable 5ml & Ultra Fine SMD Painless 5ml & 3ml found contaminated. Use may cause serious infections. Stop usage & report.
ND
by News Desk
2025-07-29
DRAP Flags Dangerous Syringes Over Sterility Concerns

KARACHI – The Drug Regulatory Authority of Pakistan (DRAP) has issued a critical safety alert after the Central Drugs Laboratory Karachi (CDL) declared multiple syringe brands as "substandard" following sterility and contamination tests.

According to the official alert, the following syringes have failed essential quality control checks:

  • Zindagi Auto Disable Syringe 5ml
  • Ultra Fine SMD Painless Syringe 5ml
  • Ultra Fine SMD Painless Syringe 3ml

The laboratory found that these syringes pose a significant risk of microbial contamination. Their use in intravenous or invasive medical procedures could lead to serious infections, including localized abscesses and life-threatening systemic complications, especially in immunocompromised patients.

DRAP stated, “All pharmacists and chemists at distribution points and retail pharmacies are instructed to immediately check their stocks and halt the sale and distribution of the affected products.” Retailers have been advised to quarantine remaining stocks and return them to the respective suppliers or companies.

The Zindagi syringe was declared substandard based on a failed sterility test, while Ultra Fine SMD Painless syringes failed both the sterility and description tests—with visible black particles detected inside the syringe barrels.

DRAP has also urged consumers to discontinue use immediately and consult healthcare professionals if any health issues arise after using these products. Patients and providers are encouraged to report adverse effects to DRAP to aid further investigation and enforcement.

This is not the first time DRAP has flagged safety issues. In March 2023, a popular fever syrup for children was recalled due to contamination. Earlier this year, the regulator also ordered the withdrawal of nine tainted syrups from the market.

The regulatory body reaffirmed its commitment to patient safety, emphasizing rigorous oversight of pharmaceutical and medical device standards across Pakistan.
Tagged:

HealthSafety

MedicalDevices

DRAPAlert
Share News: